Vaxzevria
Product Overview
Type: COVID-19 Vaccine (ChAdOx1-S ([recombinant])
INN: N/A
Trade name: Vaxzevria
EUL holder: AstraZeneca AB
Country: Sweden
Responsible NRA: National Administration of Medicines, Food and Medical Technology (ANMAT)
Country: Argentina
WHO EUL Recommendation
Effective date: 23 December 2021
Product description
Pharmaceutical Form: Suspension for injection
Presentation: 6 mL vial
Number of doses: 10 doses (0.5 mL per dose)
Route of administration: Intramuscular
Age indication: 18 years and older
Shelf – life: 6 months Storage temperature: 2°C to 8°C
Vaccine Vial monitor (VVM): None
Preservative: None
Adjuvant: None
Diluent: None
Handling of opened multi-dose vials:
WHO recommends that opened vials of this vaccine should be discarded 6 hours after opening or at the end of the immunization session, whichever comes first.
Packaging description
|
Secondary Packaging: |
a. Carton of ten vials (100 doses). Dimensions: 13.9 x 5.4 x 6.1 cm |
|
Tertiary Packaging: |
a. 24 secondary packaged cartons (1240 vials/2400 doses). Dimensions: 28.5 x 23.3 x 19.9 cm |
|
Cold Chain Volume in secondary packaging: |
a. 4.6 cm3/dose |